Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition comprising vinpocetine compound and preparation method thereof

A technology of vinpocetine and a composition, which is applied in the field of pharmaceutical preparations, can solve the problems of poor freeze-dried powder injection effect, decreased preparation stability, affected preparation quality, etc. Effect

Inactive Publication Date: 2012-08-22
HEFEI YIFAN MEDICINE MARKETING
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, the patent also discloses that after 6 months of the accelerated test of the 2004 patent, the appearance, pH value, expression content and related substances of the sample have changed significantly, indicating that the freeze-dried powder provided by the 2004 patent has a poor effect
[0007] Patent CN201010113013.1 carried out prescription screening on the basis of the patent in 2004. Using weak acids such as citric acid, tartaric acid, acetic acid, lactic acid, sorbic acid, and ascorbic acid as co-solvents requires auxiliary addition of antioxidants to jointly improve its stability. In the absence of antioxidants, the stability of the preparation will decrease significantly, and the above-mentioned acids such as citric acid, lactic acid, sorbic acid, and ascorbic acid are all physiologically active substances. For example, citric acid has anticoagulant effect, and lactic acid may cause lactic acid Poisoning, etc., which will affect the quality of the preparation to a certain extent, and hydrochloric acid is a strong acid, although the solubilization effect is good, but if it is not well controlled, the pH value of the solution will be too low. At this time, if the pH value is adjusted above 3.0 with alkali, Then Vinpocetine will crystallize out from the solution, and the inventor finds through a large number of screenings that the phosphoric acid solution of a specific concentration can be used as a cosolvent to overcome the above-mentioned defects, so a lyophilized powder made of the following components is provided: Changchun Xetine 10-30g, mannitol 70g, sorbitol 20g, 10-20% phosphoric acid 50-100ml, add water for injection to 2000ml

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition comprising vinpocetine compound and preparation method thereof
  • Pharmaceutical composition comprising vinpocetine compound and preparation method thereof
  • Pharmaceutical composition comprising vinpocetine compound and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1: Vinpocetine freeze-dried powder injection

[0030] 1. Composition (based on vinpocetine 10mg / bottle, 1000 bottles):

[0031] composition

Proportion (weight: g)

Vinpocetine

10

Sorbic acid

15

Mannitol

70

[0032] 2. Preparation method:

[0033] 1) Dissolve Vinpocetine with 200ml of water for injection, then add mannitol and sorbic acid, stir to make it completely dissolve;

[0034] 2) Adjust the pH value of the solution prepared in step 1) to 3.7 with 1mol / L sodium hydroxide, add water for injection to 2000ml, add 0.05% activated carbon for adsorption, decarbonize, and fine filter with a 0.22 μm microporous membrane;

[0035] 3) Semi-finished product inspection, filling, half-corking, freeze-drying, capping, inspection.

Embodiment 2

[0036] Embodiment 2: Vinpocetine freeze-dried powder injection

[0037] 1. Composition (based on vinpocetine 10mg / bottle, 1000 bottles):

[0038] composition

Proportion (weight: g)

Vinpocetine

10

Sorbic acid

15

Mannitol

100

[0039] 2. Preparation method:

[0040] 1) Dissolve Vinpocetine with 200ml of water for injection, then add mannitol and sorbic acid, stir to make it completely dissolve;

[0041] 2) Adjust the pH value of the solution prepared in step 1) to 4.0 with 1mol / L sodium hydroxide, add water for injection to 2000ml, add 0.05% activated carbon for adsorption, decarbonize, and fine filter with a 0.22 μm microporous membrane;

[0042] 3) Semi-finished product inspection, filling, half-corking, freeze-drying, capping, inspection.

Embodiment 3

[0043] Embodiment 3: Vinpocetine freeze-dried powder injection

[0044] 1. Composition (based on vinpocetine 10mg / bottle, 1000 bottles):

[0045] composition

Proportion (weight: g)

Vinpocetine

20

Sorbic acid

30

Mannitol

150

[0046] 2. Preparation method:

[0047] 1) Dissolve Vinpocetine with 300ml of water for injection, then add mannitol and sorbic acid, stir to make it completely dissolve;

[0048] 2) Adjust the pH value of the solution prepared in step 1) to 3.0 with 1mol / L sodium hydroxide, add water for injection to 2000ml, add 0.05% activated carbon for adsorption, decarbonize, and fine filter with a 0.22 μm microporous membrane;

[0049] 3) Semi-finished product inspection, filling, half-corking, freeze-drying, capping, inspection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition comprising a vinpocetine compound and a preparation method thereof, and the pharmaceutical composition comprises the following components vinpocetine, sorbic acid and mannitol in a weight ratio of (10-30):(5-30):(50-200). The pharmaceutical composition disclosed by the invention has the advantages of easy formation, good redissolution, stable properties and high safety, and all indicators meet the provisions on medicine use.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a pharmaceutical composition containing a vinpocetine compound and a preparation method thereof. Background technique [0002] Vinpocetine (Vinpocetine) molecular formula C 22 h 26 N 2 o 2 , is a kind of natural medicine extracted from Apocynaceae Vinca, belonging to indole alkaloids. Also known as vinblast ethyl ester, convinol, alpra vincine ethyl ester, white crystalline powder, odorless, melting point 147-153°C, soluble in chloroform and ethanol, almost insoluble in water. [0003] Vinpocetine is widely used in the prevention and treatment of ischemic cerebrovascular diseases, and is often used in cerebral arteriosclerosis, cerebral ischemic and hemorrhagic stroke sequelae, transient ischemic attacks and other cerebral circulation disorders. Symptoms induced by circulatory disorders, such as aphasia, apraxia, poor memory, cognitive impairment, vertigo and other...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4375A61K47/12A61P9/10A61P25/28A61P25/22A61P25/24A61P25/04A61P3/06A61P27/02A61P27/16A61P25/00
Inventor 罗诚
Owner HEFEI YIFAN MEDICINE MARKETING
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products